Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atlas Lithium (ATLX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Atlas Lithium (ATLX) over the last 14 years, with Q3 2025 value amounting to $21.0 million.

  • Atlas Lithium's Cash & Equivalents fell 489.36% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year decrease of 489.36%. This contributed to the annual value of $15.5 million for FY2024, which is N/A changed from last year.
  • Per Atlas Lithium's latest filing, its Cash & Equivalents stood at $21.0 million for Q3 2025, which was down 489.36% from $13.9 million recorded in Q2 2025.
  • Atlas Lithium's 5-year Cash & Equivalents high stood at $32.3 million for Q2 2024, and its period low was $18132.0 during Q3 2021.
  • For the 5-year period, Atlas Lithium's Cash & Equivalents averaged around $10.3 million, with its median value being $9.4 million (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9361.53% in 2021, then skyrocketed by 909740.18% in 2023.
  • Quarter analysis of 5 years shows Atlas Lithium's Cash & Equivalents stood at $22776.0 in 2021, then surged by 1130.94% to $280358.0 in 2022, then soared by 8052.92% to $22.9 million in 2023, then tumbled by 32.02% to $15.5 million in 2024, then skyrocketed by 35.01% to $21.0 million in 2025.
  • Its Cash & Equivalents was $21.0 million in Q3 2025, compared to $13.9 million in Q2 2025 and $14.0 million in Q1 2025.